Live Quote · NASDAQADPTHealthcare· Biotechnology

Adaptive Biotechnologies Corporation

$27.93▼ 0.43%($-0.12)
MKT CAP $4.52BNEXT EARNINGS Feb 4, 2027
50%
Bullish
TickerSpark Score
66/100
▌ Solid
27
Valuation
40
Profitability
100
Growth
64
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ADPT research report →

Analyst Price Target
$31.58+13.1% vs. today

Range $27 – $35

Analyst RatingBuy
11 Buy4 Hold2 Sell

Price Chart

+71.14% · this period
$30.26$21.34$12.41Nov 20May 26Nov 20
52-Week Range79% of range
Low
$12.00
Current
$27.93
High
$32.21